MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
68.57
+1.49 (2.22%)
Aug 14, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, MBX Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $88.4. The average 1-year stock price forecast is 28.92% higher than the current stock price, while the lowest is $70 (+2.09%) and the highest is $121 (+76.46%).
Price Target: $88.4 (+28.92%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MBX Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $70 | Buy | Maintains | $70 | +2.09% | Aug 11, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $70 → $88 | Buy | Maintains | $70 → $88 | +28.34% | Aug 10, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $91 | Buy | Reiterates | $91 | +32.71% | Aug 7, 2026 |
| Barclays | Barclays | Buy Maintains $70 → $88 | Buy | Maintains | $70 → $88 | +28.34% | Aug 7, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $121 | Buy | Reiterates | $121 | +76.46% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.12
from -2.38
EPS Next Year
-3.93
from -3.12
EPS and Forward PE are based on non-GAAP adjusted numbers.